Kopecky, Stephen L.
Mayo Clinic
11 papers on CoChatORCID 0000-0002-0506-405X
Most cited papers
- Verified
Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes.
Liuzzo, G., Goronzy, J. J., Yang, H., Kopecky, S. L., Holmes, D. R., Frye, R. L., & Weyand, C. M. (2000) · Circulation
Atherosclerosis and Cardiovascular DiseasesT-cell and B-cell Immunology
Cited by 552
- Verified
An assessment by the statin muscle safety task force: 2014 update
Rosenson, R. S., Baker, S. K., Jacobson, T. A., Kopecky, S. L., & Parker, B. A. (2014) · Journal of Clinical Lipidology
Lipoproteins and Cardiovascular HealthPharmacovigilance and Adverse Drug Reactions
Cited by 485
- Verified
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
Moriarty, P. M., Thompson, P. D., Cannon, C. P., Guyton, J. R., Bergeron, J., Zieve, F. J., Bruckert, E., Jacobson, T. A., Kopecky, S. L., Baccara-Dinet, M. T., et al. (2015) · Journal of Clinical Lipidology
Lipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism
Cited by 470
- Verified
Perturbation of the T-cell repertoire in patients with unstable angina.
Liuzzo, G., Kopecky, S. L., Frye, R. L., Fallon, W. M. O., Maseri, A., Goronzy, J. J., & Weyand, C. M. (1999) · Circulation
Atherosclerosis and Cardiovascular DiseasesT-cell and B-cell Immunology
Cited by 398
- Verified
Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation: A 30-Year Follow-Up Study
Jahangir, A., Lee, V., Friedman, P. A., Trusty, J. M., Hodge, D. O., Kopecky, S. L., Packer, D. L., Hammill, S. C., Shen, W.-K., & Gersh, B. J. (2007) · Circulation
Atrial Fibrillation Management and OutcomesCardiac electrophysiology and arrhythmias
Cited by 392
- Verified
Testosterone and Cardiovascular Disease
Kloner, R. A., Carson, C., Dobs, A., Kopecky, S., & Mohler, E. R. (2016) · Journal of the American College of Cardiology
Hormonal and reproductive studiesMenopause: Health Impacts and Treatments
Cited by 371
- Verified
T-cell-mediated lysis of endothelial cells in acute coronary syndromes
Nakajima, T., Schulte, S., Warrington, K. J., Kopecky, S. L., Frye, R. L., Goronzy, J. J., & Weyand, C. M. (2002) · Circulation
Atherosclerosis and Cardiovascular DiseasesT-cell and B-cell Immunology
Cited by 356
- Verified
Study of the Therapeutic Effects of Intercessory Prayer (STEP) in cardiac bypass patients: A multicenter randomized trial of uncertainty and certainty of receiving intercessory prayer
Benson, H., Dusek, J. A., Sherwood, J. B., Lam, P., Bethea, C. F., Carpenter, W., Levitsky, S., Hill, P. C., Clem, D. W., Jain, M. K., et al. (2006) · American Heart Journal
Religion, Spirituality, and PsychologyCardiac Health and Mental Health
Cited by 287
- Verified
De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes.
Nakajima, T., Goek, O., Zhang, X., Kopecky, S. L., Frye, R. L., Goronzy, J. J., & Weyand, C. M. (2003) · Circulation Research
Immune Cell Function and InteractionAtherosclerosis and Cardiovascular Diseases
Cited by 127
- Verified
Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac death
Nigam, A., Wright, R. S., Allison, T. G., Williams, B. A., Kopecky, S. L., Reeder, G. S., Murphy, J. G., & Jaffe, A. S. (2006) · International Journal of Cardiology
Acute Myocardial Infarction ResearchCardiovascular Function and Risk Factors
Cited by 98
- Verified
Management of Atrial Fibrillation in Adults: Prevention of Thromboembolism and Symptomatic Treatment
Blackshear, J. L., Kopecky, S. L., Litin, S. C., Safford, R. E., & Hammill, S. C. (1996) · Mayo Clinic Proceedings
Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management
Cited by 67
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free